Adjuvant chemotherapy and follow-up

Francesco Leone

doi:10.1007/978-88-470-1809-9_10

Adjuvant chemotherapy and follow-up

Francesco Leone

Istituto Oncologico Candiolo

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Even though there are no definitive data supporting the use of adjuvant chemotherapy after liver resection for initially resectable hepatic colorectal metastases, the rationale for this approach seems evident. The activity of chemotherapy in metastatic disease is well known, and it is broadly accepted that, at least theoretically, patients with micrometastatic disease after radical surgery will benefit from systemic chemotherapy, as will patients undergoing surgery for stage III colon cancer.

Original language	English
Title of host publication	Surgical Treatment of Colorectal Liver Metastases
Publisher	Springer Milan
Pages	153-158
Number of pages	6
ISBN (Print)	9788847018082
DOIs	https://doi.org/10.1007/978-88-470-1809-9_10
Publication status	Published - 2011

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1007/978-88-470-1809-9_10

Cite this

@inbook{2fd2209071514de0b9923f9d586e18cf,

title = "Adjuvant chemotherapy and follow-up",

abstract = "Even though there are no definitive data supporting the use of adjuvant chemotherapy after liver resection for initially resectable hepatic colorectal metastases, the rationale for this approach seems evident. The activity of chemotherapy in metastatic disease is well known, and it is broadly accepted that, at least theoretically, patients with micrometastatic disease after radical surgery will benefit from systemic chemotherapy, as will patients undergoing surgery for stage III colon cancer.",

author = "Francesco Leone",

year = "2011",

doi = "10.1007/978-88-470-1809-9_10",

language = "English",

isbn = "9788847018082",

pages = "153--158",

booktitle = "Surgical Treatment of Colorectal Liver Metastases",

publisher = "Springer Milan",

}

TY - CHAP

T1 - Adjuvant chemotherapy and follow-up

AU - Leone, Francesco

PY - 2011

Y1 - 2011

N2 - Even though there are no definitive data supporting the use of adjuvant chemotherapy after liver resection for initially resectable hepatic colorectal metastases, the rationale for this approach seems evident. The activity of chemotherapy in metastatic disease is well known, and it is broadly accepted that, at least theoretically, patients with micrometastatic disease after radical surgery will benefit from systemic chemotherapy, as will patients undergoing surgery for stage III colon cancer.

AB - Even though there are no definitive data supporting the use of adjuvant chemotherapy after liver resection for initially resectable hepatic colorectal metastases, the rationale for this approach seems evident. The activity of chemotherapy in metastatic disease is well known, and it is broadly accepted that, at least theoretically, patients with micrometastatic disease after radical surgery will benefit from systemic chemotherapy, as will patients undergoing surgery for stage III colon cancer.

UR - http://www.scopus.com/inward/record.url?scp=84892068065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892068065&partnerID=8YFLogxK

U2 - 10.1007/978-88-470-1809-9_10

DO - 10.1007/978-88-470-1809-9_10

M3 - Chapter

AN - SCOPUS:84892068065

SN - 9788847018082

SP - 153

EP - 158

BT - Surgical Treatment of Colorectal Liver Metastases

PB - Springer Milan

ER -

Adjuvant chemotherapy and follow-up

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this